CDRB436BDE04 - Combi-r
Laufzeit: 01.01.2016 - 31.12.2017
imported
Kurzfassung
A non-interventional, multi-centric, prospective trial of combined Dabrafenib and Trametinib treatment of advanced melanoma in the real-world setting